Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Biochemical Pharmacology|January 10, 2012
Acquired resistance to drugs targeting receptor tyrosine kinasesSteven A RosenzweigGrowth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 1, 2004
What's new in the IGF-binding proteins?Steven A RosenzweigAdvances in Cancer Research|March 20, 2018
Acquired Resistance to Drugs Targeting Tyrosine KinasesSteven A RosenzweigF1000Research|April 1, 2020
The Continuing Evolution of Insulin-like Growth Factor SignalingSteven A RosenzweigAmerican Journal of Physiology. Cell Physiology|May 14, 2004
Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19Mark G Slomiany, Steven A RosenzweigThe Journal of Pharmacology and Experimental Therapeutics|May 10, 2006
Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretionMark G Slomiany, Steven A RosenzweigBiochemistry|September 8, 2004
Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interfaceStephanie A Robinson, Steven A RosenzweigBiochemical Pharmacology|May 11, 2006
Paradoxical effects of the phage display-derived peptide antagonist IGF-F1-1 on insulin-like growth factor-1 receptor signalingStephanie A Robinson, Steven A RosenzweigBiochemical Pharmacology|July 6, 2010
Defining the pathway to insulin-like growth factor system targeting in cancerSteven A Rosenzweig, Hanudatta S AtreyaInvestigative Ophthalmology & Visual Science|July 28, 2004
IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407Mark G Slomiany, Steven A RosenzweigPageof 3